A Post-Mortem on Cassava Sciences

Zacks 11/27 04:50

Unpacking the Latest Options Trading Trends in Cassava Sciences

Benzinga11/27 03:31

SAVA Stock Plunges 84% on Alzheimer's Drug Failure in Late-Stage Study

Zacks 11/27 02:00

What's Left in Cassava After Phase 3 Setback for Alzheimer's Drug

Seeking Alpha11/27 00:17

Down -83.93% in 4 Weeks, Here's Why You Should You Buy the Dip in Cassava Sciences (SAVA)

Zacks 11/26 21:40

This Goldman Sachs Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Benzinga11/26 21:13